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ABSTRACT
Reactive astrocytes are implicated in amyotrophic
lateral sclerosis (ALS), although the mechanisms
controlling reactive transformation are unknown. We
show that decreased intron retention (IR) is com-
mon to human-induced pluripotent stem cell (hiPSC)-
derived astrocytes carrying ALS-causing mutations
in VCP, SOD1 and C9orf72. Notably, transcripts with
decreased IR and increased expression are overrep-
resented in reactivity processes including cell adhe-
sion, stress response and immune activation. This
was recapitulated in public-datasets for (i) hiPSC-
derived astrocytes stimulated with cytokines to un-
dergo reactive transformation and (ii) in vivo astro-
cytes following selective deletion of TDP-43. We also
re-examined public translatome sequencing (TRAP-
seq) of astrocytes from a SOD1 mouse model, which
revealed that transcripts upregulated in translation
significantly overlap with transcripts exhibiting de-
creased IR. Using nucleocytoplasmic fractionation of
VCP mutant astrocytes coupled with mRNA sequenc-
ing and proteomics, we identify that decreased IR
in nuclear transcripts is associated with enhanced
nonsense mediated decay and increased cytoplas-
mic expression of transcripts and proteins regulating
reactive transformation. These findings are consis-
tent with a molecular model for reactive transforma-
tion in astrocytes whereby poised nuclear reactivity-
related IR transcripts are spliced, undergo nuclear-
to-cytoplasmic translocation and translation. Our
study therefore provides new insights into the molec-




Amyotrophic lateral sclerosis (ALS) is a rapidly progres-
sive and incurable neurodegenerative disease. The patho-
logical hallmark of ALS is cytoplasmic aggregation of the
RNA-binding protein, transactive response DNA-binding
protein 43 (TDP-43, encoded by TARDBP) accompanied
by loss of nuclear TDP-43, in the motor neurons of >97%
of ALS cases (1). Since the identification of the SOD1
gene mutation in ALS, which accounts for ∼15% of fa-
milial cases, ∼30 gene mutations have been discovered of
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which C9orf72 is the most common (∼35% of familial cases)
(2,3). Valosin-containing protein (VCP) is a transitional
endoplasmic reticulum ATPase essential for maturation
of ubiquitin-containing autophagosomes, and accounts for
∼2% of familial ALS (4). Although motor neuron degener-
ation was traditionally regarded as the cellular substrate of
ALS pathogenesis, accumulating evidence implicates astro-
cytes, which play vital roles in providing neuronal support
including metabolite provision and modulating the immune
response (5–7). ALS astrocytes can non-cell autonomously
impair motor neuron function through loss of supportive
and/or gain of toxic factors, and recent studies addition-
ally revealed cell autonomous astrocyte phenotypes (8–17).
ALS postmortem studies consistently report neuroinflam-
mation and reactive gliosis (18–23). Neuroinflammation in-
duces quiescent astrocytes to undergo dramatic changes in
gene expression, morphology and function, called ‘reactive
transformation’ (24–26). Using inflammatory cues to mimic
activated microglia, Liddelow et al. profiled astrocyte gene
expression changes accompanying reactive transformation
and categorized them into pan-reactive, A1 (harmful) and
A2 (protective) responses (24,27–28).
Although gene expression changes accompanying reac-
tive responses have been extensively studied, the regulating
molecular mechanisms are unknown (24,26–27,29). Alter-
native splicing, particularly intron retention (IR), is recog-
nized as a major regulator of gene expression during both
differentiation and activation of several cell types (30–36).
Although other modes of alternative splicing (exon skip-
ping and alternative splice site usage) typically enhance pro-
tein synthesis, IR can serve to suppress translation––introns
often contain premature termination codons promoting
degradation via nonsense-mediated decay (NMD) (36,37).
IR can also regulate RNA localization by promoting nu-
clear confinement, further suppressing translation (31–
32,38–40). We recently reported aberrant IR in human-
induced pluripotent stem cell (hiPSC)-derived ALS mo-
tor neuron cultures undergoing differentiation (41,42). IR
has also been implicated in the function of other neuronal
and immune cells––orchestrated IR regulates activation of
macrophages, granulocytes and lymphocytes––however, its
role in astrocytes is unknown (30,33–34,36,42–47).
We sought to determine if alternative splicing, and specif-
ically IR, plays a role in astrocyte reactivity in ALS. Us-
ing RNA sequencing from a variety of sources (Supple-
mentary Table S1), including enriched hiPSC-derived as-
trocytes harbouring mutations in VCP, SOD1 and C9orf72,
we found the loss of thousands of IR transcripts that corre-
lates with increased abundance of their cognate spliced tran-
scripts and are enriched for astrocyte reactivity processes.
This decreased IR signature was recapitulated in both as-
trocytes stimulated with inflammatory cues to undergo re-
active transformation as well as in vivo astrocytes following
selective deletion of TDP-43, which itself triggered reactive
transformation. We additionally found that a significant
number of reactivity genes with reduced IR in ALS astro-
cytes also display increased translation. Using nucleocyto-
plasmic fractionation, we revealed that VCP mutant astro-
cytes have fewer IR transcripts in the nucleus, coupled with
enhanced NMD of cytoplasmic IR transcripts. This was
associated with increased cytoplasmic spliced mRNA and
protein that are reactivity-related, suggesting nuclear-to-
cytoplasmic translocation and translation of spliced reac-
tivity transcripts. Cumulatively this work identifies a phys-
iological and orchestrated IR programme in healthy as-
trocytes, which is lost in ALS and coincides with an in-
creased abundance of reactivity regulators, thus potentially
contributing to astrocyte reactive transformation.
MATERIALS AND METHODS
Human-induced pluripotent stem cell derived astrocytes
hiPSCs were maintained using standard protocols and were
differentiated into astrocytes as described previously, gen-
erating highly enriched (>90%) populations of astrocytes
(Supplementary Figure S1A) (8,11,48–51). hiPSCs were
maintained on Geltrex (Life Technologies) with serum-
free Essential 8 Medium media (Life Technologies), and
passaged using EDTA. After neural conversion (7 days
in a chemically defined medium containing 1 M Dorso-
morphin (Millipore), 2 M SB431542 (Tocris Bioscience)
and 3.3 M CHIR99021 (Miltenyi Biotec), neural precur-
sors were patterned for 7 days with 0.5 M retinoic acid
and 1 M purmorphamine, followed by a 4-day treatment
with 0.1 M purmorphamine. After a propagation phase
(60–120 days) with 10 ng/ml FGF-2 (Peprotech), astro-
cytes were terminally differentiated in presence of BMP4
(10 ng/ml, R&D) and LIF (10 ng/ml, Sigma-Aldrich) for
30 days. Informed consent was obtained from all patients
and healthy controls in this study. Experimental protocols
were all carried out according to approved regulations and
guidelines by UCLH’s National Hospital for Neurology
and Neurosurgery and UCL’s Institute of Neurology joint
research ethics committee (09/0272).
Nuclear and cytoplasmic RNA purification
Subcellular fractionation was achieved using the Ambion
PARIS kit (ThermoFisher Scientific) following the manu-
facturer’s protocol. The cytosolic fraction was obtained by
lysing cells in ice-cold cell fractionation buffer for 5 min,
disrupting plasma membranes while leaving nuclear mem-
branes intact. Lysates were centrifuged for 3 min at 500 ×
g at 4◦C. Supernatant was further centrifuged at maximum
speed at 4◦C for 1 min, and the resulting supernatant was
processed as the cytosolic fraction. Nuclear pellets from the
first centrifugation step were gently washed with cell frac-
tionation buffer and then lysed on ice for 30 min in 8 M
Urea Nuclear Lysis Buffer. The resulting nuclear fraction
was homogenized using a QIAshredder (Qiagen) to shred
chromatin and reduce viscosity. Both lysis buffers were sup-
plemented with 0.1 U/l RiboLock RNase Inhibitor (Ther-
moFisher Scientific) and HALT Protease Inhibitor Com-
plex (ThermoFisher Scientific).
RNA isolation and RT-qPCR
The Promega Maxwell RSC simplyRNA cells kit including
DNase treatment, alongside the Maxwell RSC instrument,
was used for RNA extractions. The Nanodrop was used to
assess RNA concentration and the 260/280 ratio, and the
Agilent TapeStation was used to assess quality. All RNA
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samples have RIN value > 8.4. RT-qPCR was performed
on cDNA generated from 50 ng DNaseI-treated total RNA
using SuperScript® IV First-Strand Synthesis System (In-
vitrogen) and random hexamers, according to the manufac-
turers’ instructions. RT-qPCR reactions were performed in
10 l volumes containing 1× SYBR® Green Mastermix
(Bio-Rad) and 0.5 M of the respective forward and re-
verse primers. Samples were amplified and analysed using
the CFX96™ Real Time PCRMachine (Bio-Rad). Cycling
conditions were: 50◦C for 2 min, 95◦C for 2 min, followed
by 40 cycles at 95◦C for 15 s, then 60 C for 60s. Samples
were run in triplicate and all programs contained a melt
curve and a no template control. The absence of contam-
inating gDNA was confirmed by PCR on negative RT sam-
ples. Fold change was calculated using the CT method.
RNA sequencing
Poly(A)+ selected reverse stranded RNA sequencing li-
braries were prepared from whole astrocyte and their nu-
clear and cytoplasmic fractions obtained from astrocyte dif-
ferentiation from three control and two VCP mutant cell
lines using the KAPA mRNA HyperPrep Library kit for Il-
lumina®, with 50 ng of total RNA as input. Libraries were
sequenced on a HiSeq 4000 platform at the Francis Crick
Institute. One control sample failed quality control and was
discarded. A total of 129 million 100 bp-long paired-end
strand-specific reads were sequenced per sample split over
five lanes. All libraries generated in this study had <1%
rRNA, <1% mtDNA, >90% strandedness and >70% ex-
onic reads (Supplementary Table S1).
Proteomics
Protein samples from nuclear and cytoplasmic fractions
were reduced, alkylated and acetone precipitated overnight.
Each protein pellet was resuspended in 1 M guanidine hy-
drochloride and 100 mM HEPES. Proteins were tryptically
digested overnight at 37◦C with mixing. Digested samples
were acidified then stored at −80◦C. Each sample was split
into triplicates and loaded onto prepared Evotips. Samples
were analysed using Evosep 15 cm column and an orbitrap
Fusion mass spectrometer operating in data-dependent ac-
quisition mode. A 44-minute universal (OT/IT) method was
used. Raw files were analysed with MaxQuant v1.6.12.0 us-
ing the LFQ algorithm against a 2020 SwissProt Homo sapi-
ens protein database.
Western blotting
Protein lysates were loaded onto NuPAGE, 4–12%, Bis-
Tris protein gels (Invitrogen) and subjected to electrophore-
sis before being transferred onto nitrocellulose membrane
(Biorad). Blocking was performed in PBS, 0.1% tween, 5%
bovine serum albumin for 1 h at room temperature and
incubated overnight with mouse anti -Tubulin (1:1000,
Sigma T5168) and rabbit anti-histone 3 (1:1000, Abcam
ab179). Following washes, membranes were incubated for
1 h at room temperature with fluorescent secondary anti-
rabbit and anti-mouse antibody (1:10000, LI-COR IRDye).
Membranes were imaged using Odyssey Fc Imaging System
(LI-COR).
Statistical analyses
Raw mRNA sequencing reads were aligned to hg38 hu-
man reference genome using splice-aware aligner, STAR
v2.6.1 (52). Aligned reads were quantified with HTSeq
v0.12.4 (53) using intersection-strict mode to enable count-
ing of spliced transcripts at gene-level based on Ensembl
GRCh 38.99 annotation. Detailed quality control of the
raw RNAseq was assessed utilizing the nf-core/rna-seq
pipeline (54) (Supplementary Tables S1, S3). Differential
gene expression was measured using DESeq2 (55) in R
v4.0.3. Results were generated by comparing the mutant
(or treated, or cytoplasmic fraction) versus control (or un-
treated, or nuclear fraction) and a gene was considered
significantly differentially expressed if false discovery rate
(FDR) < 0.05.
Alternative splicing was quantified using both a cover-
age based tool, VAST-TOOLS (56) and a splice-junction
tool, SGSeq (57). IR focused analysis was quantified us-
ing IRFinder, (58) which measures IR levels using the IR
ratio metric (intron read depth divided by the sum of the
intron and flanking exon read depth, Figure 1B). IRFinder
addresses specific peculiarities in IR quantification includ-
ing: low complexity regions, non-poly(A)+ RNA and DNA
contamination, and overlapping exons. To improve consis-
tency in the quantification of IR only ‘clean’ events are
included, filtering out spurious IR events with reliability
warnings LowCover (spliced reads mapping across the 3′
and 5′ flanking exons + intron reads > 10) and LowSplic-
ing (> 4 reads from across the 3′ and 5′ flanking exons) in
the IRFinder-IR-dir.txt output. Differential IR was quanti-
fied using analysisWithLowReplicates.pl from IRFinder be-
tween mutant and control, using the Audic and Claverie test
and threshold of P < 0.05 (uncorrected for multiple test-
ing). To assess the relationship between differential gene
expression and IR, we assigned the log2foldchange in its
gene expression (mutant versus control) to the IR ra-
tio for each reliable differential IR event. To identify en-
riched functional pathways, Gene Ontology (GO) enrich-
ment was performed using g:Profiler2 (59). Significantly
over-represented (FDR < 0.05) up and downregulated IR
genes were grouped according to their differential gene ex-
pression directional change and these subsets were used as
input, with all measured genes used as background. In the
barcharts the top significant GO terms were manually cu-
rated by removing redundant terms. Gene set enrichment
analysis (GSEA) was performed using the fgsea R pack-
age (60) on the transcriptomic signature gene sets for NMD
components (61) and Liddelow et al. reactivity genes (24).
Overlapping gene lists between datasets were tested using
the Fisher’s exact test. Similarly, Liddelow et al. reactivity
genes with reduced IR were tested for overlap with genes in-
creased in expression using the Fisher’s exact test. For Lid-
delow et al. genes with multiple reliable IR ratios, we cal-
culated the genes mean IR ratio, normalizing for each re-
tained introns length.
Features of retained and spliced introns (length, GC con-
tent, PhastCons conservation score) were analysed as re-
ported previously (36,42). To identify RBPs that bind to
aberrantly retained introns, we examined iCLIP data for 21
RBPs (62), and eCLIP data from HepG2 cells for 112 RBPs
available from ENCODE (63). Relative enrichment for each
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of the RBPs was obtained by calculating the proportion of
crosslink events mapping to retained introns compared with
non-retained introns of the same genes. Maximum Entropy
splice site scoring software (MaxEntScan) was used to pre-
dict the splice site strength for the 5′ splice sites (5′ ss) and
3′ splice sites (3′ ss) (64). The 5′ss score uses 9-bases (last 3
bases of the upstream exon and first 6 bases of the intron),
whereas the 3′ss score uses 23-bases (last 20 bases of intron
and first 3 bases of the downstream exon). We determined
the MaxEntScan score for retained introns, using all 5′ ss
(exon–intron junctions) and 3′ ss (intron–exon junctions) of
annotated introns, using the GencoDymo R package. NMD
probability was predicted by searching for premature termi-
nation codons in the open reading frame of transcripts con-
taining retained introns, using GeneStructureTools and not-
NMD bioconductor packages. Differential transcript-level
isoform expression analysis was performed with Kallisto
(65) and transcript biotypes were annotated using the En-
sembl biotype classification to enable comparison between
NMD and protein coding annotated transcripts.
For comparison with SOD1 and C9orf72 mutant hiPSC
astrocytes, we downloaded RNAseq data from Tyzack
et al. (8) (GSE102902 and GSE99843) and Birger et al.
(66) (GSE142730). SOD1G37R mouse spinal cord astro-
cyte TRAP-Seq was downloaded from Sun et al. (67)
(GSE74724). For comparison with hiPSC stimulated reac-
tive astrocyte dataset, we downloaded bulk RNAseq from
Barbar et al. (27) (synapse ID: 21861229). For TDP-43
deleted mouse astrocytes, we accessed bulk RNAseq from
Peng et al. (68) (GSE156542). RNAseq from these studies
were processed using the same pipeline as described above
and quality control metrics are reported in Supplementary
Table S1. Sequencing depth was on average ∼50 million
reads per sample, which ranged from 10 million in SOD1
to 129 million in VCP mutant astrocytes. Lower sequenc-
ing depth limits the ability to detect IR; however, using the
stable IRFinder algorithm, we were able to identify reli-
able IR events even at 10 million albeit at lower absolute
numbers (Supplementary Figure S3) (8,69). Mass spectrom-
etry proteomics data were analysed using DEP package
(v1.11.0) (70) on MaxQuant results. Data were filtered, nor-
malized and imputed using default parameters. Differen-
tial enrichment analysis was performed using protein-wise
linear models combined with Bayes statistics that utilizes
limma. A protein was considered significantly differentially
expressed when P < 0.05 (uncorrected for multiple compar-
isons). Schematics were created with BioRender.com. All er-
ror bars shown represent either the standard error of the
mean (SEM) or 1.5 times the interquartile range, from in-
dependent experiments.
RESULTS
Intron retention is decreased in ALS astrocytes across VCP,
SOD1 and C9orf72 mutants
To identify transcriptome-wide changes in ALS astro-
cytes, we performed RNA sequencing on poly(A)+ selected
mRNA libraries isolated from highly enriched and func-
tional hiPSC-derived astrocytes using our previously es-
tablished platform (Supplementary Figure S1A) (8,11,49–
50,71). Specifically, we first examined RNA sequencing
from two lines derived from two patients with ALS-causing
VCP gene mutations (p.R155C and p.R191Q) and two
healthy control lines (Figure 1A) (8,11,49). To improve
confidence in detecting differential splicing, libraries were
deeply sequenced to ∼130 million reads per sample (Supple-
mentary Table S2). Principal component analysis and un-
supervised hierarchical clustering demonstrated that sam-
ples segregated based on genotype (Supplementary Figure
S1B–D). We first defined differences between VCP mutant
and control astrocyte gene expression patterns and found
170 differentially expressed genes (FDR < 0.05), which is
11-fold more than what we previously established in termi-
nally differentiated VCP mutant motor neurons (41). Dif-
ferentially expressed genes were enriched for developmen-
tal, structural and nervous system processes (Supplemen-
tary Figure S1E and Supplementary Table S3).
We sought to examine alternative splicing in hiPSC-
derived astrocytes, comparing those carrying VCP muta-
tions to control counterparts. After examining all modes
of alternative splicing and finding that only IR was signif-
icantly different between VCP mutant and control astro-
cytes (Supplementary Figure S2A and B), we focused fur-
ther on IR quantification (Figure 1B) (58). Across both con-
ditions, we found 16,317 reliable unique retained introns
(IR ratio > 0.1 i.e. intron abundance is ≥ 10% of the sum
of intron + spliced abundance); however, there were 14.1%
fewer retained introns in VCP mutant compared with con-
trol (12,169 versus 14,162, respectively, Supplementary Fig-
ure S3A). Differential IR comparison revealed 2,309 introns
with reliable coverage from 1,699 genes that were retained at
significantly different levels (P < 0.05, Audic and Claverie
test, Supplementary Figure S3B), with 1,885 (81.6%) dis-
playing decreased IR in VCP (Figure 1C, 1F; P = 2.39 ×
10−68), confirming reduced IR in VCP mutant astrocytes.
To assess whether IR was also reduced in other ALS
mutant astrocytes, we analysed published C9orf72 (66)
and SOD1 (8) mutant astrocyte RNA sequencing datasets
(C9orf72 dataset: two mutant and two control lines; SOD1
dataset: one mutant and two control lines) (Supplemen-
tary Table S1). In both datasets we identified dramati-
cally less retained introns in ALS mutants compared with
control (C9orf72: 7,925 versus 14,937 [47% less, Supple-
mentary Figure S3C]; SOD1: 3,602 versus 7,842 [54% less,
Supplementary Figure S3E] respectively, Figure 1C). In
C9orf72 astrocytes, 448 introns in 376 genes were signifi-
cantly differentially retained, of which 93% (416/448) were
decreased in C9orf72 relative to control (Supplementary
Figure S3D). In SOD1 mutant astrocytes, 139 introns in 131
genes showed significant differential retention of which 59%
(82/139) were reduced in SOD1 mutants compared with
control (Supplementary Figure S3F). These findings from
across five ALS mutant and six control lines, when taken
together, strongly indicate that decreased IR in astrocytes is
common across diverse genetic forms of ALS.
To investigate whether ALS mutant astrocytes exhibit de-
creased IR within the same genes, we overlapped genes with
IR events between VCP, C9orf72 and SOD1 mutants. Com-
paring genes exhibiting decreased IR between VCP and
C9orf72 datasets, revealed a significant overlap of 129 / 347
(37.2%, P = 2.0 × 10−118, Fisher’s exact test; Figure 1D).
Likewise, VCP and SOD1 mutants, shared 31 / 76 (40.1%,
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Figure 1. RNA-sequencing reveals loss of intron retention in ALS astrocytes. (A) Schematic depicting human-induced pluripotent stem cells (hiPSC)
astrocyte differentiation and fractionation in ALS (red) and control (blue). Astrocytes were subjected to RNA-sequencing and were analysed for differential
gene expression and alternative splicing, with a focus on intron retention. We then mapped the spliced-transcript expression and intron retention values of
each gene. See Supplementary Figure S1A for stepwise differentiation strategy of iPSC-derived astrocytes. Two hiPSC lines were obtained from two ALS
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P = 9.0 × 10−31) genes with decreased IR (Supplementary
Table S4). Ten genes with decreased IR were common to
all three mutations (chi-squared P = 0.005), of which six
are relevant to reactivity: FLNA, PLOD3, MRC2, ACTN4,
GPS2 and MCAM (28,72). This significant overlap between
independent ALS datasets recapitulates our observation in
VCP mutant astrocytes, suggesting that diminished IR of
astrocyte reactivity genes is generalizable across ALS mu-
tations.
Consistent with prior studies, retained introns in all three
datasets (i.e. VCP, C9orf72 and SOD1 mutant ALS as-
trocytes) exhibited significantly shorter lengths, higher GC
content, higher conservation score, higher predicted bind-
ing affinities to RNA-binding proteins (RBPs) and lower
splice site strength compared with spliced introns (Supple-
mentary Figure S4A) (36,73–74). Introns with significantly
decreased retention in any of the three ALS mutants ex-
hibited longer lengths, lower GC content, and lower RBP-
binding affinities but similar conservation scores compared
with gained introns (Figure 1E) (63,75). Although 3′ splice
site strengths were similar between increased and decreased
IR events, the 5′ splice site strengths were higher in de-
creased IR events, consistent with increased activity of the
spliceosome machinery in ALS astrocytes (64). Scanning
for premature termination codons (PTC) within the open
reading frame of intronic sequences revealed that the prob-
ability of NMD was significantly lower in IR transcripts
decreased in ALS compared to IR transcripts increased in
ALS. These observations were generally consistent between
VCP, C9orf72 and SOD1 mutants (Supplementary Figure
S4B) and confirm previous studies demonstrating that cis
features define an ‘IR code’ (36,42,45).
Decreased intron retention and increased expression of astro-
cyte reactivity regulators is generalizable across ALS astro-
cytes
To understand the consequences of decreased IR in ALS as-
trocytes on gene expression, for each gene we mapped lev-
els of IR to expression (Figure 1A). Previous studies indi-
cate that decreased IR can lead to increased gene expression
through avoiding NMD (30,76–77). Comparing changes in
IR with changes in gene expression, we found that genes
with decreased IR had higher expression compared with
genes with increased IR in VCP mutant versus control as-
trocytes (t-test P = 2.6 × 10−11; Figure 2A). Correlating
changes in IR with changes in gene expression between VCP
mutant and control revealed a negative association (Pear-
son R = −0.20, Figure 2B), consistent with a relationship
between transcripts with decreased IR and increased ex-
pression of their spliced isoforms. Of 817 genes with in-
creased expression and exhibiting a reliable IR event, 702
(85.9%) exhibited decreased IR in VCP mutant astrocytes.
Restricting to genes with significantly increased expression
in VCP mutant astrocytes (FDR < 0.05) and a reliable
IR event, revealed that all four were also significantly de-
creased in IR (ERAP2, PTPRN, IL20RB, and KCNE4; Fig-
ure 2K). Using gene ontology analysis, we found genes with
reduced IR and increased expression in VCP mutant astro-
cytes were over-represented in pathways associated with cell
adhesion (e.g. TGFB1I1, COL7A1, TNC, RECK, ERAP2),
stress response (e.g. STX4, PTPRN, SLC26A6, NUP199,
HSF4) and immune activation (e.g. LOXL3, NFKB2, HLA-
B and HLA-C) - processes involved in astrocyte reactivity
(Figure 2E) (78–80). Conversely, genes with increased IR
and increased expression in VCP mutant astrocytes were
enriched for enzyme activity rather than reactivity related
terms (Supplementary Figure S5A). Of the Liddelow et
al. (24) astrocyte reactivity genes with a reliable IR event,
21/31 were decreased in IR and 15/31 were increased in
expression, while 10/31 exhibited both (32%; overlap P =
0.056; Figure 2H). Taken together, these data suggest an
inverse relationship between IR and expression, with VCP
mutant astrocytes exhibiting decreased IR and increased ex-
pression of genes regulating astrocyte reactivity.
Similar to VCP mutant astrocytes, for both C9orf72 and
SOD1 mutants, genes with decreased IR exhibited signif-
icantly increased gene expression, whereas genes with in-
creased IR correlated with decreased expression (C9orf72:
P = 4.5 × 10−8; SOD1: P = 1.5 × 10−4; Figure 2A). Ad-
ditionally, both C9orf72 and SOD1 mutants exhibited a
negative correlation between changes in IR and changes in
gene expression (C9orf72 R = -0.05; SOD1 R = -0.09; Fig-
ure 2C and D). Gene ontology analysis revealed transcripts
with decreased IR and increased expression were also over-
represented in astrocyte reactivity pathways (Figure 2F and
G; Supplementary Figure S5B and C). Of the Liddelow et
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
patients with VCP mutations (R155C and R191Q) and two healthy controls. (B) Schematic of IR quantification and differential IR calculation between
mutant and control. Median intron coverage is calculated after excluding non-unique multi-mapping reads, overlapping exons (blue) and outliers (highest
and lowest 30%) depicted by the shaded regions. Exon and intron read abundance is normalized for feature length. IR ratio is calculated as intron abundance
divided by the sum of intron and spliced abundance. Reliable IR event expression is defined as (1) spliced reads mapping across the 3′ and 5′ flanking exons
+ intron reads > 10 and (2) > 4 reads from across the 3′ and 5′ flanking exons. Delta IR ratio is calculated as mutant minus control IR ratio. Adapted
from Wong et al. (36) and Middleton et al. (58). (C) Violin plot showing delta IR ratio in ALS mutants minus control across differential intron retention
events. Intron retention was significantly downregulated in VCP (red, n = 2309), C9orf72 (light blue, n = 448) and SOD1 (green, n = 139) astrocytes versus
CTRL (one-sample t-test, **** represents P < 0.0001). (D) Venn diagram showing the number of overlapping genes with decreased intron retention events
in VCP (red), C9orf72 (blue) and SOD1 (green). Gene overlap exhibiting decreased IR between SOD1 and VCP datasets was 31/76 (40.1%, P = 1.8 ×
10−18, hypergeometric test). C9orf72 and VCP overlap was 129 / 347 (37.2%, P = 1.8 × 10−67. Overlapping all three mutants chi-squared P = 0.005. (E)
Violin plots showing intron characteristics (GC content; intron length; phastCons conservation score; iCLIP crosslinking with RBPs; 5′ and 3′ Maximum
Entropy Scores); and nonsense mediated decay (NMD) probability of upregulated versus downregulated retained introns in ALS mutants (VCP, C9orf72
and SOD1) versus control astrocytes (IR down, n = 2339; IR up, n = 490; **** represents adjusted P values from Wilcoxon test < 0.0001, *** < 0.001, **
P < 0.01). For intron characteristics of individual ALS mutants see Supplementary Figure S4B. (F) Coverage plots of reads per million from VCP mRNA
sequencing reads for RND3, SLC26A6, HSF4 and PIMREG genes. Within each are alignment tracks for CTRL (top) and VCP (bottom) astrocytes.
Ensembl transcript annotation tracks are shown above the alignment tracks with exons (thick blue boxes) and introns (thin blue arrowed lines). Vertical
red dashed lines show the retained intron of interest and the IR ratio is labelled above the retained intron. Y-axis limits for each track are auto-adjusted to
the peak exon coverage so that the target feature fills the view and enables easier visual comparison of IR ratios between conditions.
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Figure 2. Intron retention is associated with increased expression of genes involved with astrocyte reactivity. (A) Violin plots showing log2 fold change
in gene expression (Y-axis) in downregulated IR events (blue) and upregulated IR events (red) for VCP (IR down, n = 1885; IR up, n = 424), C9orf72
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al. (24) astrocyte reactivity genes exhibiting a reliable IR
event, we observed decreased IR and increased expression
in 44% (11/25, overlap P = 0.0002) for C9orf72 mutants and
42% (8/19, overlap P = 0.0002) for SOD1 mutants (Figure
2I and J). Comparing genes exhibiting decreased IR and in-
creased expression in SOD1 mutants with VCP mutants re-
vealed a significant overlap of 18/55 (33%, P = 1.1 × 10−21,
hypergeometric test; Supplementary Figure S5D). Likewise,
of the 251 genes exhibiting decreased IR and increased ex-
pression in C9orf72, 70 (28%) were also found in VCP mu-
tants (P = 2.7 × 10−75; Supplementary Table S5). Six genes
with decreased IR and increased expression were common
to all three mutations (chi-squared P = 0.008), of which four
are directly relevant to reactivity: FLNA, PLOD3, MRC2
and ACTN4 (28,72). This significant overlap between inde-
pendent ALS datasets recapitulates our observation in VCP
mutant astrocytes, demonstrating that diminished IR and
enhanced expression of astrocyte reactivity genes are gen-
eralizable across ALS mutations.
Stimulating reactive transformation using inflammatory cues
recapitulates decreased intron retention and increased expres-
sion of reactivity genes
Having established that astrocytes with a range of familial
ALS mutations exhibit reduced IR, we sought to determine
if artificially stimulating astrocyte reactivity with inflam-
matory cytokines (TNF, IL-1 and C1q) was sufficient
to induce the same effect (Figure 3A) (27). By analysing
RNA sequencing from Barbar et al. hiPSC-derived astro-
cytes stimulated to undergo reactive transformation (three
reactive and three untreated lines) (27), we identified 11%
less retained introns in astrocytes stimulated with TNF,
IL-1 and C1q compared with untreated (basal) astro-
cytes (2,143 versus 2,402, respectively; Supplementary Fig-
ure S3G). Differential IR analysis revealed 578 introns from
430 genes that were retained at significantly different levels,
with 304 (53%) being reduced in cytokine-stimulated astro-
cytes (Figure 3D, S3H; one-sample t-test P = 0.001), indi-
cating reduced IR in hiPSC-derived reactive astrocytes. Of
the 240 genes with decreased IR in cytokine-stimulated as-
trocytes, 86 (35.8%) also exhibited decreased IR in the ALS
astrocytes (overlap P = 3.8 × 10−71; Supplementary Table
S4). Taken together, we find that IR is prevalent in healthy
quiescent hiPSC-derived astrocytes but that ALS astrocytes
(with VCP, SOD1 and C9orf72 mutations) as well as astro-
cytes stimulated using TNF, IL-1, and C1q, share a com-
mon decreased IR signature.
By comparing gene expression with IR after cytokine-
stimulation in control astrocytes, we observed that genes
with decreased IR in stimulated astrocytes had significantly
higher gene expression (P < 2.22 × 10−16; Figure 3E). Fur-
thermore, IR events with greater decreases in the IR ratio
exhibited larger increases in gene expression (R = −0.34,
Figure 3F). Enrichment analysis of genes with decreased
IR and increased expression reveals that they are over-
represented in pathways associated with cellular compart-
ments, RNA metabolism and collagen processing, analo-
gous to processes implicated in ALS astrocytes (Figure 3H).
Of the Liddelow et al. (24) reactivity genes with a reliable
IR event, 11/32 (34%) exhibited both decreased IR and in-
creased expression (overlap P = 0.005, Figure 3K). Com-
paring genes with decreased IR and increased expression
between stimulated astrocytes and ALS astrocytes revealed
an overlap of 45/189 (23.8%, overlap P = 4.2 × 10−40), of
which 17 are directly relevant to astrocyte reactivity (Sup-
plementary Table S5) (8,26,81). This indicates that stimu-
lating astrocyte reactivity via established pro-inflammatory
cues reproduces reduced IR and increased expression in
similar reactivity related genes as ALS astrocytes.
In vivo astrocytes with selective deletion of TDP-43 exhibit
decreased intron retention
To further explore the molecular causes associated with de-
creased IR in ALS astrocytes, we next investigated the role
of TDP-43 in this context given its salience as a patholog-
ical hallmark in motor neurons. To address this, we lever-
aged RNA sequencing data from a recent in vivo study that
demonstrated A1-like reactive transformation in astrocytes
upon TDP-43 depletion (68). We sought to determine if this
mouse spinal cord astrocyte-specific TARDBP knockout
(TDP-43 deletion) influenced IR (four knockout and four
control mice; Figure 3B). This revealed 11% less retained
introns in TDP-43 deleted astrocytes compared with con-
trol (12,716 versus 14,338 respectively; Supplementary Fig-
ure S3I). Differential IR analysis revealed 700 introns from
643 genes that were retained at significantly different lev-
els (P < 0.05, Supplementary Figure S3J), with 581 (83%)
being decreased (Figure 3D; one-sample t-test P = 1.10 ×
10−20), indicating that astrocyte TDP-43 deletion induces a
global reduction in IR. Comparing genes with decreased IR
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
(IR down, n = 416; IR up, n = 32), SOD1 (IR down, n = 82; IR up, n = 57). Student’s t-test was used to determine significance (**** indicates P <
0.0001, *** P < 0.001). (B-D) Scatterplots of the  IR ratio (ALS minus control, X-axis) against log2 fold change in gene expression (y-axis) in VCP
(B), C9ORF72 (C) and SOD1 (D) versus control astrocytes. Points are coloured by mean gene expression across mutant and control (red = high, blue =
low expression). Black dashed line indicates linear regression correlation (VCP pearson correlation, R = −0.20; C9orf72 R = −0.05, SOD1 R = −0.09).
Grey dotted lines indicate the points of no difference between ALS versus control astrocytes for IR ratio (X-axis) and gene expression (Y-axis). Reactivity
related transcripts with IR down and expression up are labelled. See Figure 2E–G for processes enriched amongst genes in the IR down and expression
up quadrant. For the three remaining quadrants see Supplementary Figure S5A–C. (E–G) Bar graphs showing significantly over-represented functional
categories (FDR < 0.05) determined by gene ontology analysis of transcripts with reduced IR and increased expression in VCP (E), C9orf72 (F), SOD1
(G) versus control astrocytes. (H–J) Heatmaps of pan-reactive (black), A1 specific (red), and A2 specific (blue) markers from Liddelow et al., 2017 (24).
IR and gene expression (GE) data represent the log2 fold change in VCP (J), C9orf72 (K), SOD1 (L) versus control astrocytes. (K) Coverage plots of reads
per million from VCP mRNA sequencing reads for differentially expressed genes ERAP2 and PTPRN genes. Within each are alignment tracks for CTRL
(top) and VCP (bottom) astrocytes. Ensembl transcript annotation tracks are shown above the alignment tracks with exons (thick blue boxes) and introns
(thin blue arrowed lines). Vertical red dashed lines show the retained intron of interest and the IR ratio is labelled above the retained intron. Y-axis limits
for each track are auto-adjusted to the peak exon coverage so that the target feature fills the view and enables easier visual comparison of IR ratios between
conditions.
3176 Nucleic Acids Research, 2021, Vol. 49, No. 6
Figure 3. Loss of intron retention and increased expression of astrocyte reactivity genes is in reproduced cytokine stimulation of astrocytes in vitro and
astrocyte TDP-43 deletion in vivo, which coincides with increased translation in SOD1G37R astrocytes. (A–C) Schematics depicting (A) in vitro inducing
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between TDP-43 deleted astrocytes and ALS astrocytes re-
vealed an overlap of 139/525 (26.5%, P = 1.2 × 10−92; Sup-
plementary Table S4). These results indicate that astrocyte
TDP-43 is required to maintain the abundant physiological
IR levels and the loss of TDP-43 may trigger the decrease
in IR we have revealed in ALS astrocytes.
By comparing gene expression with IR in TDP-43 deleted
astrocytes, we observed that genes with decreased IR had
significantly higher gene expression (P = 0.01, Figure 3E).
Consistent with the other datasets, we found a negative cor-
relation between changes in IR and changes in gene expres-
sion (R = −0.07; Figure 3G). Also similar to both ALS
and cytokine-stimulated astrocytes, gene ontology analysis
showed that they are enriched in metabolic processes, cel-
lular compartments and RNA binding (Figure 3I). Of the
Liddelow et al. (24) astrocyte reactivity genes with a reliable
IR event, 12/31 (39%) were decreased in IR and increased in
expression (overlap P = 0.01, Figure 3L). Comparing genes
with decreased IR and increased expression between the
TDP-43 deleted astrocytes and the ALS astrocytes revealed
an overlap of 46/269 (17.1%, P = 4.6 × 10−34), of which 19
are directly relevant to astrocyte reactivity (Supplementary
Table S5) (26). This suggests that astrocyte TDP-43 deple-
tion recapitulates reduced IR and increased expression in
similar reactivity related genes as ALS astrocytes.
Reactivity genes with decreased IR in ALS astrocytes are
translated in a SOD1 mouse model of ALS
To determine whether decreased IR in ALS astrocytes in-
fluences translation of astrocyte reactivity genes, we exam-
ined a translating ribosome affinity purified RNA sequenc-
ing (TRAP-Seq) dataset from Sun et al. (Figure 3C) (67).
SOD1G37R mutant mouse spinal cord astrocytes were iso-
lated and mRNAs bound to ribosome subunits were se-
quenced enabling interrogation of these translating mR-
NAs (four SOD1G37R and six control samples). In concor-
dance with Sun et al., we found that SOD1G37R astrocytes
exhibit upregulation of inflammatory pathways (Figure 3J
and Supplementary Figure S5G) as well as established as-
trocyte reactivity genes (24) (enrichment P = 7.3 × 10−10;
Figure 3M). Comparing genes with significantly increased
translation in Sun et al. (FDR < 0.05) with those with de-
creased IR in ALS astrocytes, revealed 44/429 (9%, P = 9.2
× 10−14) overlapping genes, of which 32 are directly rele-
vant to astrocyte reactivity, including OSMR, FBLN5, VIM
and PTX3 (Supplementary Table S4) (26). Additionally, of
the genes exhibiting decreased IR in stimulated reactive as-
trocytes, 6/223 (P = 0.01) displayed increased translation
in SOD1G37R mouse astrocytes, of which all eight were de-
creased in IR in ALS astrocytes. Similarly, in the astrocyte
TDP-43 deleted mouse, 17 genes with decreased IR were
increased in translation in SOD1G37R astrocytes (P = 4.4
× 10−7), of which 7 were also decreased in IR in ALS mu-
tants. Collectively, these data suggest that decreased IR in
ALS astrocytes is correlated with translation of reactivity
genes.
Decreased nuclear intron retention is associated with in-
creased cytoplasmic spliced reactivity transcripts and protein
in VCP mutant astrocytes
To gain further mechanistic insight into reactive trans-
formation of astrocytes, we examined the nuclear and
cytoplasmic transcriptomes and proteomes in VCP mu-
tant astrocytes. To achieve this we performed nuclear–
cytoplasmic fractionation of astrocytes, followed by high
depth poly(A)+ selected RNA sequencing and mass spec-
trometry (Figure 4A). Fractionation quality was confirmed
by determining that transcripts known to localize to the nu-
cleus (histone H3, intronic GAPDH, NEAT, MALAT1) or
cytoplasm (exonic GAPDH, Tubulin) were enriched in the
expected compartment, using western blot (Figure 4B), RT-
qPCR (Figure 4C), RNA sequencing (Supplementary Fig-
ure S6A) and mass spectrometry (Supplementary Figure
S6B) of both VCP mutant and control astrocytes (40,82).
Principal component analysis and unsupervised hierarchi-
cal clustering demonstrated that samples segregated based
on both fraction (nuclear or cytoplasmic) and genotype
(Supplementary Figure S6C and D).
To determine the subcellular location of intron-retaining
transcripts, IR focused analysis was performed on nuclear
and cytoplasmic isolates. This revealed 5.8-fold more re-
tained introns in nuclear than cytoplasmic fractions (41,138
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
astrocyte reactivity with inflammatory cues (TNF, IL-1, C1q) in hiPSC-derived control astrocytes, (B) in vivo astrocyte-specific TDP-43 deletion using
conditional GFAP-Cre recombinase promoter. Spinal cord was dissected and mRNA extracted before RNA sequencing, and (C) ALS SOD1G37R mutant
mouse with astrocyte-specific (Aldh1l1) bacTRAP reporter, which expresses the EGFP-tagged ribosome protein (Rpl10a) within astrocytes. Polyribosome-
associated mRNAs undergoing translation are then isolated by EGFP immunoprecipitation before mRNA purification and RNA translatome sequencing.
(D) Violin plot showing delta IR ratio in reactive astrocytes (blue, left, n = 578) and TDP43 deletion (red, right, n = 700) minus control across differential
intron retention events. Intron retention was significantly downregulated in both cytokine stimulated astrocytes and TDP43 deleted astrocytes (one-sample
t-test, **** represents P < 0.0001 and ** P < 0.01). (E) Violin plots showing log2 fold change in gene expression (reactive state versus control, y-axis)
in downregulated IR events (blue) and upregulated IR events (red) for cytokine stimulated (IR down, n = 304; IR up, n = 274) and TDP-43 deleted (ko,
knockdown) (IR down, n = 581; IR up, n = 119). Student’s t-test was used to determine significance (**** indicates P < 0.0001, * P < 0.05). (F and G)
Scatterplots of the  IR ratio (reactive state minus control, x-axis) against log2 fold change in gene expression (y-axis) in (F) cytokine stimulated and (G)
TDP43 deleted versus control astrocytes. Points are coloured by mean gene expression across mutant and control (red = high, blue = low expression).
Black dashed line indicates linear regression correlation (cytokine stimulated Pearson correlation R = −0.34; TDP43 deleted R = −0.07). Reactivity related
genes with IR down and expression up are labelled. See Figure 3H–I for processes enriched amongst genes in the IR down and expression up quadrant. (H
and I) Bar graphs showing significantly over-represented functional categories (FDR < 0.05) determined by gene ontology analysis of genes with reduced
IR and increased gene expression in cytokine stimulated (H) and TDP43 deleted (I). See Supplementary Figure S5E and F for the other IR and expression
categories. (J) Bar graph showing curated significantly over-represented functional categories (FDR < 0.05) determined by gene ontology analysis of genes
with increased translation in SOD1G37R versus control mouse spinal cord astrocytes. See Supplementary Figure S5G for genes decreased in translation.
(K and L) Heatmaps of pan-reactive (black), A1 specific (red) and A2 specific (blue) markers from Liddelow et al., 2017 (24). IR and gene expression (GE)
data represent the log2 fold change in cytokine stimulated (K) and TDP43 deleted (L) versus control astrocytes. (M) Heatmap of pan-reactive, A1 specific
and A2 specific markers in astrocyte translatome data log2 fold change in SOD1G37R versus control samples.
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Figure 4. Decreased nuclear intron retention coincides with increased cytoplasmic spliced reactivity transcripts and protein in VCP mutant astrocytes. (A)
Schematic of astrocyte fractionation into nuclear and cytoplasmic compartments followed by RNA sequencing and mass spectrometry. (B: western blot of
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versus 7,036, respectively, Supplementary Figure S7C and
D), consistent with previous reports (38,74,82). Of the
16,317 retained introns identified in whole astrocytes, 92%
(n = 14,952) were observed in nuclear isolates, 40% (n =
6,493) in cytoplasmic isolates, while 37% (n = 6,059) were
observed in both (Supplementary Figure S7E). Retained
introns in both nuclear and cytoplasmic fractions exhib-
ited similar characteristics as in whole astrocytes (shorter
in length, higher in GC content, conservation score, RBP
binding affinity and lower in splice site strength; Supple-
mentary Figure S8A–F).
Although we observed a reduction in the absolute num-
bers of retained introns in VCP mutant relative to con-
trol in both the nucleus (7% less, 34,464 versus 36,943, re-
spectively) and the cytoplasm, this reduction was substan-
tially greater in the cytoplasm (58% less, 2,791 versus 6,607).
Comparing IR levels between VCP and control, revealed
1.8-fold more significantly differentially retained introns in
the cytoplasm (5,138 in 3,065 genes; Supplementary Figure
S7B) than the nucleus (2,915 in 2,079 genes; Supplemen-
tary Figure S7A). These were decreased in VCP mutants in
both nuclear (1882/2915, 65%) and cytoplasmic fractions
(5089/5138, 99%; Figure 4D, Supplementary Figure S9).
Comparing this decrease between the cytoplasm and nu-
cleus confirmed that the cytoplasmic decrease was signifi-
cantly greater (wilcoxon test, P < 2.22 × 10−16). This ex-
cessive cytoplasmic decrease raises the possibility that IR
transcripts in VCP mutant astrocytes are subject to either
(i) increased nuclear confinement or (ii) enhanced cytoplas-
mic degradation.
To establish whether differentially retained introns in
VCP mutant astrocytes differed between the nucleus and
cytoplasm, we next examined their IR characteristics. Al-
though similar patterns were noted for GC content, we
found that nuclear retained introns that were decreased
in VCP mutants were shorter, higher in conservation and
weaker in RBP binding, compared to introns gained in VCP
(Supplementary Figure S8G–L). Conversely, cytoplasmic
retained introns decreased in VCP mutants were longer,
lower in conservation and stronger in RBP binding. These
opposing nuclear and cytoplasmic IR transcript patterns
between VCP and control astrocytes support either altered
nuclear-to-cytoplasmic transport or differential stability.
To ascertain the degree to which IR transcripts are nu-
clear confined in VCP mutant astrocytes, we compared
IR between cytoplasmic and nuclear fractions. Although
we noted 10% more differentially retained introns in VCP
(31,358 events in 9,630 genes) than control (28,447 events in
9,459 genes), the proportion of these that were increased in
the nucleus (i.e. nuclear confined) was 99.9% in both condi-
tions (control: 28 410/28 447; VCP: 31 330/31 358). Com-
paring this nuclear confinement between VCP and control
showed no significant difference (wilcoxon test, P = 0.66;
Figure 4E). This striking but similar nuclear confinement
in both control and VCP indicates that astrocytes use IR
coupled with nuclear confinement as a strategy to regulate
gene expression, consistent with reports in other cell types
(30,82).
However, this still leaves unresolved the excessive cyto-
plasmic decrease in IR within VCP mutant astrocytes. To
begin to address this, we next examined NMD to estab-
lish whether cytoplasmic degradation is responsible for the
disproportionate loss of IR. Gene set enrichment analy-
sis of the NMD gene set (n = 120) in the cytoplasmic
fraction revealed significant upregulation in VCP (normal-
ized enrichment score 1.15, enrichment P = 0.049), with
94/120 (78%) of the NMD genes being increased (Figure
4F; one-sample wilcoxon test P = 2.36 × 10−7). By per-
forming differential spliced transcript-level isoform expres-
sion analysis in VCP versus control fractions and compar-
ing transcripts annotated as NMD substrates with those
annotated as protein coding biotypes, we found that cyto-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
histone 3 (bottom, nuclear marker) and Tubulin (top, cytoplasmic marker) in nuclear (left) and cytoplasmic (right) protein from control (ctrl1, ctrl2) and
VCP (R155C, R191Q) astrocytes. Gaps indicate non-adjacent samples run on the same blot. (C) RT-qPCR of nuclear markers intronic GAPDH, Malat1,
NEAT and cytoplasmic marker exonic GAPDH transcript fold enrichment in nuclear and cytoplasmic fractions from control and VCP mutant astrocytes.
Data are from two replicates for each sample and show mean ± SD. (D) Violin plot showing  IR ratio across differential intron retention events in nuclear
(red, n = 5138) and cytoplasmic (blue, n = 2915) fractions. One-sample wilcoxon test adjusted P = 1.94e-47 and P < 2.00e-145 respectively, **** represents
P value < 0.0001). Comparing cytoplasmic and nuclear groups with the wilcoxon test showed significantly greater decreases in IR (VCP versus control) in
cytoplasmic than nuclear fraction (P < 2.2 × 10−16). (E) Violin plot showing  IR ratio (cytoplasmic minus nuclear fractions) across differential IR events
in VCP (blue, n = 31 358) and CTRL (red, n = 28 447). One-sample wilcoxon tests P < 2.00e-145 for both. Comparing VCP and CTRL groups showed
no differences in nuclear confinement (wilcoxon test P = 0.66). (F) Nonsense mediated decay (NMD) components (n = 120) gene set enrichment analysis
of log2 fold changes (LFC) in gene expression (VCP versus CTRL) in the cytoplasmic fraction. One-sample wilcoxon test P = 2.36 × 10−7. (G) Violin
plots showing log2 fold changes in transcript isoform expression in VCP versus CTRL for transcripts annotated in Ensembl as nonsense mediated decay
(NMD tx) and protein coding (non-NMD tx) biotypes in cytoplasmic (left, NMD tx n = 16 370, non-NMD tx n = 91 880, wilcoxon P < 2.2 × 10−16)
and nuclear fractions (right, NMD tx n = 16 370, non-NMD tx n = 91 880, wilcoxon P = 0.11). (H) Violin plot showing log2 fold change (VCP versus
control) in cytoplasmic transcript abundance for upregulated (blue, n = 1033) and downregulated (red, n = 1882) nuclear IR events (VCP minus control).
Student’s t-test was used to compare IR up with IR down. (I) Scatterplot of the nuclear  IR ratio (VCP minus control) against log2 fold change (LFC) in
cytoplasmic spliced transcript abundance in VCP versus control. Black dashed line indicates linear regression correlation (Pearson correlation R = −0.21).
Reactivity related genes with nuclear IR down and cytoplasmic expression up are labelled. (J) Bar graph showing curated overrepresented functional
categories (FDR < 0.05) by gene ontology analysis of genes with reduced nuclear IR and increased cytoplasmic mRNA abundance, in VCP versus control.
See Supplementary Figure S7G for GO terms in other IR and expression categories. (K) Violin plot showing log fold change (VCP versus control) in
cytoplasmic mass spectrometry (protein) intensities for upregulated (blue, n = 621) and downregulated (red, n = 413) nuclear IR events (VCP minus
control). Student’s t-test was used to compare IR up with IR down (P = 0.14). (L) Scatterplot of the nuclear  IR ratio (nuclear VCP minus nuclear
control, x-axis) against log fold change (LFC) in mass spectrometry (y-axis) in VCP versus control cytoplasmic fractions. Black dashed line indicates linear
regression correlation (Pearson correlation, R = −0.06). Reactivity related genes with nuclear IR down and cytoplasmic protein up are labelled. (M) Bar
graph showing curated overrepresented functional categories (FDR < 0.05) by gene ontology analysis of genes with reduced nuclear IR and increased
cytoplasmic protein abundance, in VCP versus control. See Supplementary Figure S7H for GO terms in other IR and protein categories. (N) Heatmap of
astrocyte reactivity markers from Liddelow et al., 2017. Nuclear intron retention (IR), cytoplasmic gene expression (Cyto mRNA) and cytoplasmic mass
spectrometry (Cyto protein) data represent the log fold change in VCP versus control.
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plasmic NMD substrate transcripts exhibited significantly
lower expression than protein coding biotypes in VCP mu-
tant cytoplasm (wilcoxon P < 2.2 × 10−16). Compara-
tively there was no significant difference between differen-
tial transcript expression between NMD and protein cod-
ing biotypes in the nuclear fraction (P = 0.11; Figure 4G).
This contrast between nuclear and cytoplasmic differen-
tial transcript expression according to NMD transcript an-
notation supports enhanced cytoplasmic NMD activity in
VCP mutant astrocytes. Taken together, this suggests that
increased cytoplasmic NMD activity underlies the excessive
cytoplasmic degradation of IR transcripts in VCP mutant
astrocytes.
To explore whether the nuclear confinement of IR tran-
scripts determines cytoplasmic expression, we next mapped
nuclear IR to cytoplasmic spliced transcript abundance.
Genes with decreased nuclear IR in VCP mutant astrocytes
displayed higher cytoplasmic spliced transcript abundance
than genes with increased IR (P = 1.71 × 10−35, R = −0.21;
Figure 4H and I), suggesting that spliced transcripts are
more likely to be exported from the nucleus. Genes with re-
duced nuclear IR and increased cytoplasmic spliced tran-
script abundance were over-represented in astrocyte reac-
tivity processes: cell adhesion (MCAM, COL1A1, ILK),
translation (EIF2B4, EIF5, EIF3A) and immune activation
(HLA-B, HLA-C, TGFB1; Figure 4J). NMD was also en-
riched, indicating NMD component transcripts themselves
are subject to enhanced splicing and cytoplasmic transloca-
tion. Of the astrocyte reactivity genes identified in Liddelow
et al. (24) with a reliable IR event, we observed decreased
nuclear IR and increased cytoplasmic expression in 11/30
markers (37%, overlap P = 0.002; Figure 4N).
Using mass spectrometry, we detected 1160 proteins in
the cytoplasmic fractions of which 580 were increased in
protein levels in VCP versus control (Supplementary Ta-
ble S6). Of these 580 proteins, 500 had a reliable IR event,
of which 299 (60%) were decreased in nuclear IR and of
these, the majority (155/299, 52%) are involved with re-
active transformation. Across the entire cytoplasmic pro-
teome, we found no significant difference in protein abun-
dance between those whose cognate transcripts exhibited
decreased compared with increased nuclear IR in VCP ver-
sus control astrocytes (wilcoxon test P = 0.46; Figure 4K).
However, correlating changes in nuclear IR with changes
in cytoplasmic protein abundance revealed a negative cor-
relation (R = −0.06; Figure 4L), indicating that decreased
nuclear IR is associated with increased cytoplasmic pro-
tein. Genes with reduced nuclear IR and increased cyto-
plasmic protein abundance were over-represented in the in-
fection response, cell adhesion, RNA processing as well
as NMD, indicating that an increase in protein levels is
a specific phenomenon amongst astrocyte reactivity pro-
cesses (Figure 4M). Seven of the Liddelow astrocyte reac-
tivity genes were detected in cytoplasmic mass spectrometry
of which HSPB1 and HLA-E were both increased in VCP
mutants, which were also increased in cytoplasmic mRNA
(Figure 4N). Comparing cytoplasmic mRNA and protein
abundance changes in VCP versus control revealed signif-
icantly increased mRNA fold changes than that of pro-
tein (wilcoxon test P = 3.74 × 10−4; Supplementary Fig-
ure S7F), implicating enhanced cytoplasmic mRNA decay
within VCP mutant astrocytes. These findings together sug-
gest that under normal circumstances astrocytes employ IR
to achieve nuclear confinement of ‘poised’ reactivity tran-
scripts; however in VCP mutant astrocytes increased splic-
ing releases them to the cytoplasm permitting their transla-
tion (depicted in graphical abstract).
DISCUSSION
Recent advances in astrocyte biology have implicated re-
active astrocytes in ALS pathogenesis (14,22–23,29,81,83).
However, despite this accumulating evidence (5–7) and
the increased availability of transcriptomic data (8,27,66),
the molecular determinants of astrocyte gene expression
changes that drive reactive transformation have remained
unknown. Although previous transcriptome-wide analyses
exposed the reactive nature of ALS astrocytes, they mostly
relied on differential gene expression rather than alterna-
tive splicing methods (8–9,23,29,66). Combining expression
with splicing analyses of the astrocyte transcriptome, cou-
pled with translatome and proteome data, we find that IR
is prevalent in healthy quiescent hiPSC-derived astrocytes
but that ALS astrocytes share a common decreased IR
signature, which is a conserved phenomenon across VCP,
C9orf72 and SOD1 mutations. This is reproduced in pub-
licly available RNA sequencing datasets in both (i) astro-
cytes stimulated with TNF, IL-1 and C1q to undergo
reactive transformation (a modest 53% decrease albeit sta-
tistically significant) and (ii) astrocytes depleted in TDP-43
in vivo (more substantial 83% decrease). Transcripts with
decreased IR in ALS and reactive astrocytes displayed in-
creased expression and were over-represented in astrocyte
reactivity pathways, supporting IR as a post-transcriptional
repressor of reactive transformation (30–32). Furthermore,
by re-examining public translational profiling of SOD1G37R
mouse spinal cord astrocytes (67), we observed increased
translation of astrocyte reactivity genes that exhibited de-
creased IR in ALS astrocytes (26). Our study provides in-
sight into the molecular factors regulating reactive trans-
formation of ALS astrocytes, whereby decreased IR might
serve to post-transcriptionally enhance astrocyte reactivity
genes.
These findings differ substantially from what we and oth-
ers have established in ALS motor neurons carrying diverse
mutations, which exhibit increased IR (41–42,44,46,84–86).
Although motor neurons and astrocytes are derived from
the same neural precursor cell, they evidently show strik-
ing differences in IR regulation during terminal differenti-
ation. Instead, the association between decreased IR and
astrocyte reactivity resembles other immune cells, such as
lymphocytes and macrophages, where there is an inverse re-
lationship between global IR levels and the cellular activa-
tion state (31–34,47). We speculate that the opposing shift in
IR between motor neurons and astrocytes is a consequence
of distinct cell-type responses to ALS pathogenic processes,
such as TDP-43 proteinopathy (71), extrinsic stressors (87),
neuronal injury (8,88) or even reactive transformation itself.
Although VCP, C9orf72 and SOD1 mutations are patholog-
ically distinct with divergent effects, a common theme is that
they are each linked to perturbed RNA processing and/or
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RBP mislocalization, which may be responsible for these
ALS cell-type specific alterations in IR (3,41). In support
of this, TDP-43 mislocalization triggers neurons to upreg-
ulate immune response pathways (NF-kB and type 1 inter-
feron) via the cGAS-STING pathway (89), whereas TDP-
43 proteinopathy in astrocytes has been shown to be asso-
ciated with metabolic dysregulation via cAMP and calcium
signalling (90). These divergent responses of astrocytes and
motor neurons may differentially affect key splicing factors,
provoking deregulation of the spliceosome complex and al-
tering its finely-tuned ability to recognize and act on splic-
ing signals (91–93). Future functional studies with cell-type
specific targeted disruption of spliceosome components, as
well as splicing enhancers and repressors, would help to
elucidate the mechanisms of this differential IR shift and
whether it directly contributes to disease pathogenesis (94).
It has been proposed that intron-containing mRNAs may
function to encourage their nuclear confinement, prevent-
ing nuclear leak and translation (74,82). Thus, an important
question is whether transcripts exhibiting decreased IR in
ALS astrocytes are able to escape nuclear confinement and
undergo nuclear-export. To address this, we used nuclear-
cytoplasmic fractionation and found decreased IR in both
nuclear and cytoplasmic compartments in VCP mutant as-
trocytes. We identified more than double the number of dif-
ferential IR events (VCP mutant versus control) in the cyto-
plasm (5,138) than the nucleus (1,882) and although there
was an overall decrease in IR in both VCP fractions, the
proportion lost was dramatically greater in the cytoplasm
(99% versus 65%). Although there was no change in the
strength of nuclear confinement of IR transcripts, there was
a substantial loss of transcripts annotated as NMD sub-
strates from the cytoplasm in VCP mutant astrocytes. We
further established that NMD components exhibited de-
creased nuclear IR and increased cytoplasmic abundance
in VCP mutant astrocytes. This suggests that, together with
astrocyte reactivity transcripts, NMD components are sub-
ject to enhanced splicing enabling their cytoplasmic translo-
cation. While it is possible that other mechanisms regulat-
ing IR transcripts in the cytoplasm are responsible, such as
targeted subcellular localization, RBP sequestering or cyto-
plasmic splicing, the most likely explanation for the exces-
sive cytoplasmic degradation of IR transcripts in VCP mu-
tant astrocytes is enhanced NMD activity (42,95–96). This
raises the possibility that NMD itself is a key part of reac-
tive transformation, which would be consistent with stud-
ies reporting that IR-NMD coupling has additional roles
in regulating the stress response, beyond its well established
post-transcriptional quality control mechanism serving to
degrade PTC-containing IR transcripts (35–36,74,97–101).
Indeed, perturbed IR-NMD crosstalk has been shown in
neuroinflammation and ALS, where it may act to liberate
bound RBPs for further splicing modulation (32,102–105).
Consistent with enhanced NMD in VCP mutant astro-
cytes, we also found that nuclear transcripts with decreased
IR manifest higher cytoplasmic spliced transcript abun-
dance than nuclear transcripts with increased IR. We ob-
served a major cluster of astrocyte reactivity related genes
in VCP mutant astrocytes that are subject to loss of nu-
clear IR and increased cytoplasmic spliced transcript abun-
dance, including many of the established astrocyte reactiv-
ity genes identified by Liddelow et al. (24). Interestingly, of
these we found multiple HLA class 1 genes, which when
overexpressed protect motor neurons from reactive astro-
cyte toxicity (106). Within this cluster we also identified
enrichment of other genes involved with the extracellular-
matrix (e.g. COL1A1, MMP24, ADAM19), focal adhe-
sion (e.g. MCAM, ILK, EPHA2, ITGB1) and immune-
activation (e.g. TGFB1, NFKB1, NFKB2, CD68, IL32),
consistent with processes previously identified in ALS as-
trocytes (8,15–16,29,66). This indicates that transcripts reg-
ulating multiple facets of astrocyte reactivity exhibit en-
hanced nuclear splicing in VCP mutant astrocytes that may
allow nuclear-export to the cytoplasm for translation, facil-
itating reactive transformation.
Overall, our study provides new insights into the co-
ordinated role of IR coupled with gene expression in as-
trocytes and its aberration in ALS. Astrocytes employ IR
to post-transcriptionally repress reactivity genes; however,
ALS astrocytes undergo augmented splicing and lose this
homeostatic regulation, which may be an initial compen-
satory mechanism that may become maladaptive over time.
Further investigation into the impact of this phenomenon
on neighbouring neurons will enable an improved under-
standing of ALS, as well as other neurodegenerative dis-
eases characterized by aberrant astrocyte reactivity. Our
study raises the prospect of therapeutically targeting astro-
cyte reactivity through reinstating the physiological IR pro-
gramme by manipulation of the splicing process, for exam-
ple using antisense oligonucleotides.
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